- Home
- SVM vs IMNM Comparison
SVM vs IMNM Comparison
Compare SVM & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVM
- IMNM
- Stock Information
- Founded
- SVM N/A
- IMNM 2006
- Country
- SVM Canada
- IMNM United States
- Employees
- SVM N/A
- IMNM 131
- Industry
- SVM Precious Metals
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- SVM Basic Materials
- IMNM Health Care
- Exchange
- SVM Nasdaq
- IMNM Nasdaq
- Market Cap
- SVM 769.7M
- IMNM 748.3M
- IPO Year
- SVM N/A
- IMNM 2020
- Fundamental
- Price
- SVM $3.90
- IMNM $8.76
- Analyst Decision
- SVM Strong Buy
- IMNM Strong Buy
- Analyst Count
- SVM 1
- IMNM 5
- Target Price
- SVM $6.25
- IMNM $26.40
- AVG Volume (30 Days)
- SVM 5.8M
- IMNM 973.9K
- Earning Date
- SVM 05-22-2025
- IMNM 05-12-2025
- Dividend Yield
- SVM 0.64%
- IMNM N/A
- EPS Growth
- SVM 40.00
- IMNM N/A
- EPS
- SVM 0.28
- IMNM N/A
- Revenue
- SVM $298,895,000.00
- IMNM $10,938,000.00
- Revenue This Year
- SVM $1.10
- IMNM N/A
- Revenue Next Year
- SVM $26.47
- IMNM $542.22
- P/E Ratio
- SVM $14.70
- IMNM N/A
- Revenue Growth
- SVM 38.90
- IMNM N/A
- 52 Week Low
- SVM $2.87
- IMNM $5.15
- 52 Week High
- SVM $5.32
- IMNM $16.81
- Technical
- Relative Strength Index (RSI)
- SVM 54.97
- IMNM 58.34
- Support Level
- SVM $3.57
- IMNM $7.83
- Resistance Level
- SVM $4.07
- IMNM $9.04
- Average True Range (ATR)
- SVM 0.17
- IMNM 0.53
- MACD
- SVM 0.03
- IMNM 0.07
- Stochastic Oscillator
- SVM 70.18
- IMNM 82.97
About SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is a mineral mining company. It acquires, explores, develops, and mines precious and base metal mineral properties at its producing mines and exploration and development projects in China. The group produces silver, gold, lead, and zinc. The company creates shareholder's value by focusing on generating free cash flow from long-life mines; organic growth through extensive drilling for discovery; equity investments in potential world-class opportunities; ongoing merger and acquisition efforts to unlock value; and long-term commitment to responsible mining and ESG. The Company's producing mines are located in China, and current exploration and development projects are located in China and Mexico.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.